Psychometric validation of the Bulgarian Ankylosing Spondylitis Quality of Life (ASQoL) questionnaire: linking quality of life with disease activity in axial spondyloarthritis. [PDF]
Pencheva DT +5 more
europepmc +1 more source
Race as a determinant of clinical characteristics, treatments, and outcomes of axial spondyloarthritis in the United States. [PDF]
Bakewell C, Deodhar A, Wright GC.
europepmc +1 more source
Hematological Indices as Potential Biomarkers of Disease Activity in Ankylosing Spondylitis: LASSO-Based Multivariable Modelling. [PDF]
Kaymaz-Tahra S, Taşkın C, Tanoglu A.
europepmc +1 more source
Temporomandibular joint manifestation of autoimmune diseases. [PDF]
Al-Bageah H +6 more
europepmc +1 more source
Effect of secukinumab dose escalation on MRI-detected inflammation and structural damage in axial spondyloarthritis: a clinical, investigator-initiated, treat-to-target study (TRACE). [PDF]
Vladimirova N +11 more
europepmc +1 more source
Integrated long-read transcriptomic profiling of peripheral blood from ankylosing spondylitis patients identifies regulatory shifts and core genes associated with programmed cell death. [PDF]
Cao X +7 more
europepmc +1 more source
Impact of symptom duration on the short- and long-term efficacy of bimekizumab in axial spondyloarthritis: results up to 2 years. [PDF]
Ramiro S +10 more
europepmc +1 more source

